AR
Advisory Research Portfolio holdings
AUM
$651M
1-Year Return
25.02%
This Quarter Return
+31.97%
1 Year Return
+25.02%
3 Year Return
+143.09%
5 Year Return
+422.22%
10 Year Return
+498.78%
AUM
$1.12B
AUM Growth
-$319M
(-22%)
Cap. Flow
-$574M
Cap. Flow
% of AUM
-51.07%
Top 10 Holdings %
Top 10 Hldgs %
21.26%
Holding
360
New
82
Increased
64
Reduced
136
Closed
54
Top Buys
| 1 |
AbbVie
ABBV
|
$17M |
| 2 |
Broadridge
BR
|
$15.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
$13.4M |
| 4 |
Dominion Energy
D
|
$10.7M |
| 5 |
D.R. Horton
DHI
|
$10.2M |
Top Sells
| 1 |
CORE
Core Mark Holding Co., Inc.
CORE
|
$31.7M |
| 2 |
Rio Tinto
RIO
|
$29.1M |
| 3 |
Zurn Elkay Water Solutions
ZWS
|
$28.7M |
| 4 |
Cannae Holdings
CNNE
|
$27.4M |
| 5 |
Microsoft
MSFT
|
$25.7M |
Sector Composition
| 1 | Consumer Discretionary | 17.12% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14% |
| 4 | Industrials | 10.56% |
| 5 | Healthcare | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
251
DELISTED
Immunomedics Inc
IMMU
| $443K | 0.04% |
+12,494
| New | +$443K |
|
252
T Rowe Price
TROW
$23.8B
| $438K | 0.04% |
3,548
+444
| +14% | +$54.8K |
|
253
Paylocity
PCTY
$9.62B
| $433K | 0.04% |
2,965
-11,160
| -79% | -$1.63M |
|
|
ZNGA
254
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $425K | 0.04% |
44,500
-179
| -0.4% | -$1.71K |
|
255
Constellation Brands
STZ
$26.2B
| $416K | 0.04% |
+2,376
| New | +$416K |
|
256
Apple
AAPL
$3.56T
| $405K | 0.04% |
4,440
-1,044
| -19% | -$95.2K |
|
257
Vanguard Intermediate-Term Treasury ETF
VGIT
$32.4B
| $403K | 0.04% |
5,712
| – | – |
|
258
Unilever
UL
$158B
| $402K | 0.04% |
7,317
-3,478
| -32% | -$191K |
|
|
SGI
259
Somnigroup International Inc.
SGI
$18.3B
| $402K | 0.04% |
22,364
+2,808
| +14% | +$50.5K |
|
260
Frontdoor
FTDR
$4.59B
| $400K | 0.04% |
+9,024
| New | +$400K |
|
261
MidCap Financial Investment
MFIC
$1.22B
| $394K | 0.04% |
41,207
-39,825
| -49% | -$381K |
|
262
Insulet
PODD
$24.5B
| $394K | 0.04% |
2,028
-677
| -25% | -$132K |
|
263
Sarepta Therapeutics
SRPT
$1.96B
| $394K | 0.04% |
+2,456
| New | +$394K |
|
264
ODP
ODP
$668M
| $392K | 0.03% |
+16,663
| New | +$392K |
|
265
TG Therapeutics
TGTX
$5.11B
| $386K | 0.03% |
+19,806
| New | +$386K |
|
266
Axon Enterprise
AXON
$57.2B
| $380K | 0.03% |
3,871
-20,706
| -84% | -$2.03M |
|
267
Exact Sciences
EXAS
$10.2B
| $380K | 0.03% |
4,370
-1,598
| -27% | -$139K |
|
268
Best Buy
BBY
$16.1B
| $360K | 0.03% |
+4,123
| New | +$360K |
|
269
Lennar Class A
LEN
$36.7B
| $359K | 0.03% |
+6,010
| New | +$359K |
|
|
270
Rio Tinto
RIO
$104B
| $359K | 0.03% |
6,392
-518,554
| -99% | -$29.1M |
|
271
Altria Group
MO
$112B
| $349K | 0.03% |
8,880
| – | – |
|
272
Okta
OKTA
$16.1B
| $349K | 0.03% |
1,741
-891
| -34% | -$179K |
|
273
CrowdStrike
CRWD
$105B
| $346K | 0.03% |
3,453
-1,897
| -35% | -$190K |
|
274
Trex
TREX
$6.93B
| $345K | 0.03% |
5,306
-5,722
| -52% | -$372K |
|
275
Veeva Systems
VEEV
$44.7B
| $341K | 0.03% |
1,455
-567
| -28% | -$133K |
|